| P50 | author | Daniel H Solomon | Q91503755 |
| P2093 | author name string | Katherine P Liao | |
| P2860 | cites work | Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis | Q34182804 |
| | Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity | Q34238357 |
| | Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis | Q34315745 |
| | Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies | Q34889152 |
| | Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis | Q35630128 |
| | Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies | Q35863952 |
| | The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis | Q35864053 |
| | Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis | Q36098818 |
| | Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis. | Q36190844 |
| | Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register | Q36732112 |
| | Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial. | Q36901936 |
| | Role of inflammation in atherosclerosis associated with rheumatoid arthritis | Q37300182 |
| | Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm | Q38115132 |
| | An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy | Q39110166 |
| | Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation | Q43742848 |
| | Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis | Q46222728 |
| | Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. | Q51922378 |
| P433 | issue | 2 | |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 327-329 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | Editorial: inflammation, disease-modifying antirheumatic drugs, lipids, and cardiovascular risk in rheumatoid arthritis | |
| P478 | volume | 67 | |